ImmunoPrecise Antibodies Ltd. - Common Stock (IPA)
0.3526
+0.0234 (7.11%)
Immunoprecise Antibodies Ltd is a biotechnology company that specializes in the development and production of high-quality antibodies and related therapeutics for use in various biomedical applications
The company offers a range of services, including custom antibody production, protein engineering, and diagnostic assay development, catering to the needs of researchers and pharmaceutical companies. With a focus on advancing personalized medicine and supporting drug discovery, Immunoprecise Antibodies aims to provide innovative solutions that enhance the effectiveness of therapeutic treatments across multiple disease areas.
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
ImmunoPrecise Antibodies launches BioStrand's LENSaiAPI software, enhancing AI-driven drug discovery and data integration for healthcare and pharmaceutical industries.
Immunoprecise Antibodies partners with InterSystems to integrate Vector Search of IRIS data platform with BioStrand's LENSai for AI-driven healthcare solutions. Revolutionize drug discovery with precise, scalable data analysis.
IPA stock results show that ImmunoPrecise Antibodies missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2024.
Shares of HighPeak Energy, Inc. (NASDAQHPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
Even though we speak, listen, read and write every day, language is incredibly complex and ever-evolving. Context is critical to understanding. In the English language, there are a plethora of words that are spelled the same but have vastly different meanings depending on their context.
U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0.06% to 14,221.51. The S&P 500 also fell, dropping, 0.05% to 4,564.73.
ImmunoPrecise Antibodies Ltd (NASDAQIPA) shares are trading lower by 23% to $1.19 Wednesday afternoon after the company announced pricing of a $1.1 million public offering of common shares at
U.S. stocks traded mostly flat midway through trading, with the S&P 500 turning lower on Wednesday. The Dow traded up 0.01% to 36,126.75 while the NASDAQ rose 0.03% to 14,233.77. The S&P 500 also fell, dropping, 0.05% to 4,565.09.
U.S. stocks traded higher this morning, following the release of economic reports on Wednesday. Following the market opening Wednesday, the Dow traded up 0.21% to 36,200.86 while the NASDAQ rose 0.28% to 14,270.30. The S&P 500 also rose, gaining, 0.32% to 4,581.88.
